Tatva Chintan Pharma Chem Limited

NSE:TATVA.NS

856.35 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 52.0996.1434.5577.8195.04169.59116.2371.1297.97175.1228.07324.12231.46211.19208.7535.5667.1
Depreciation & Amortization 0065.8367.7760.1225.3123.8323.080000017.6000
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital 0000000000000-338.13000
Accounts Receivables 0000000000000-333.21000
Change In Inventory 0000000000000-25.75000
Change In Accounts Payables 00000000000000000
Other Working Capital 000000000000020.83000
Other Non Cash Items -52.09-96.14-34.55-77.81-95.04-169.59-116.23-71.12-97.97-175.1-228.07-324.12-231.4678.68-208.75-35.56-67.1
Operating Cash Flow 00131.66135.54120.2450.6247.6646.1600000-30.66000
Investing Activities:
Investments In Property Plant And Equipment 0000000000000-103.31000
Acquisitions Net 00000000000000000
Purchases Of Investments 00000000000000000
Sales Maturities Of Investments 00000000000000000
Other Investing Activites 0000000000000-0.9000
Investing Cash Flow 0000000000000-104.21000
Financing Activities:
Debt Repayment 0000000000000-32.44000
Common Stock Issued 00000000000000000
Common Stock Repurchased 00000000000000000
Dividends Paid 00000000000000000
Other Financing Activities 0000000000000127.6000
Financing Cash Flow 000000000000095.16000
Other Information:
Effect Of Forex Changes On Cash 000000000000084.52000
Net Change In Cash 00131.66135.54120.2450.6247.6646.160000044.81000
Cash At End Of Period 001,569.141,437.48429.35309.11934.47886.81000044.8144.81000